Menu Search
Equities

Reliq Health Technologies Inc

MHN2:DEU

Reliq Health Technologies Inc

Actions
  • Price (EUR)0.12
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-69.23%
  • Beta--
Data delayed at least 15 minutes, as of Jan 18 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Reliq Health Technologies Inc. is a Canada-based global healthcare technology company that specializes in developing virtual care solutions. The Company's target markets include virtual care, long-term care and big data. iUGO Care, the Company's platform, is a software as a service solution that supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, remote therapeutic monitoring and wound care. Its behavioral health integration service supports patients with any mental, behavioral, or psychiatric health diagnoses by integrating mental health, psychiatric care, counseling, and addiction services with primary care.

  • Revenue in CAD (TTM)14.62m
  • Net income in CAD-457.61k
  • Incorporated2005
  • Employees--
  • Location
    Reliq Health Technologies Inc406A - 175 Longwood Rd S.HAMILTON L8P 0A1CanadaCAN
  • Phone+1 (604) 687-2038
  • Fax+1 (604) 687-3141
  • Websitehttps://www.reliqhealth.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.